PC-300 Tea Effect on Triglyceride Levels

Status Completed

Clinical Trial Summary

Herbal medicine represents an alternative for treating dyslipidemia. The aim of this project was to evaluate the PC-300 tea (Eryngium heterophyllum egelm + Amphipterygium adstringens) against hypertriglyceridemia.

Baseline samples of serum total cholesterol and triglycerides were obtained and measured again after 1 month of treatment with the following two alternatives: 1) PC-300, one cup half an hour before eating, and 2) bezafibrate 200 mg/d.

Clinical Trial Description

It was a descriptive, prospective, longitudinal, and comparative clinical study developed at Ciprés Grupo Médico S.C. (CGM), Toluca, Mexico, from January 2014 to December 2014.

Patients with hypertriglyceridemia were invited to participate in the study. Voluntary subjects were assigned sequentially into two treatment groups: 1) fibrate (bezafibrate) 200 mg/day, and 2) PC-300 tea, one cup half an hour before eating.

Patients were measured (m) and weighed (kg) (Obi, México). Body mass index (BMI) was calculated as weight (kg) divided by height (m) squared. Blood pressure was measured with a calibrated sphygmomanometer (Welch Allyn, USA) after 5 min of rest.

All of the patients were given a low lipid diet. Calculated kcal were based on ideal weight minus 200 kcal/day if overweight.

Results were expressed as mean ± Standard deviation (SD). Differences between initial vs. final values were compared with the Mann-Whitney U test. The normality hypothesis was tested using the Kolmogorov-Smirnov test. A p value of <0.05 was considered significant. All tests were performed with the SPSS ver. 23 statistical software program. ;

Study Design

Related Conditions & MeSH terms

Hypertriglyceridemia

Clinical Trial Details

NCT number	NCT03649269
Study type	Interventional
Source	Ciprés Grupo Médico CGM SC
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2014
Completion date	December 31, 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03929198` - Translation of Pritikin Program to the Community	N/A
Completed	`NCT02250105` - Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia	Phase 2
Completed	`NCT02859129` - Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®)	Phase 1
Completed	`NCT01455844` - TRIal For Efficacy of Capre on hyperTriglyceridemiA	Phase 2
Completed	`NCT01437930` - Intervention With n-3 Polyunsaturated Fatty Acids (PUFA)-Supplemented Products in Moderate Hypertriglyceridemic Patients	N/A
Completed	`NCT01010399` - Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects	Phase 4
Completed	`NCT00959842` - Effects of Lovaza on Lipoprotein Composition and Function in Mild Hypertriglyceridemia	Phase 1/Phase 2
Completed	`NCT00519714` - A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA)	Phase 2/Phase 3
Recruiting	`NCT00186537` - Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.	N/A
Completed	`NCT00246402` - Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV	N/A
Completed	`NCT06020950` - Chia Seeds Consumption in Hypertriglyceridemia	N/A
Completed	`NCT02354976` - A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.	Phase 2
Completed	`NCT04966494` - Impact of Beans and Oats Snack Bar on Hypertriglyceridemic Women	N/A
Completed	`NCT04650152` - Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrome (TRISTAN)
Completed	`NCT04630366` - A Phase 1, First Time in Humans Study of NST-1024	Phase 1
Completed	`NCT03693131` - Efficacy of MND-2119 in Participants With Hypertriglyceridemia	Phase 3
Completed	`NCT04756180` - An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.	Phase 3
Completed	`NCT02868177` - Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes	Phase 2/Phase 3
Completed	`NCT01968720` - Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia	Phase 2
Completed	`NCT01462877` - A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic	Phase 4